| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:736300 | 6480464 | Dinitrochlorobenzene results in increased expression of GPNMB mRNA | CTD | PMID:16314067 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:733525 | 6480464 | Ethinyl Estradiol affects the expression of GPNMB mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of GPNMB mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | decreases expression | ISO | RGD:736300 | 6480464 | Estradiol results in decreased expression of GPNMB mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | decreases expression | ISO | RGD:736300 | 6480464 | Estradiol results in decreased expression of GPNMB mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | multiple interactions | ISO | RGD:736300 | 6480464 | Raloxifene inhibits the reaction [Estradiol results in decreased expression of GPNMB mRNA] | CTD | PMID:21185374 |
| 17beta-estradiol | multiple interactions | ISO | RGD:736300 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GPNMB mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736300 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GPNMB mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733525 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPNMB mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GPNMB mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:736300 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPNMB mRNA | CTD | PMID:19619570 |
| 3-methylcholanthrene | increases expression | ISO | RGD:733525 | 6480464 | Methylcholanthrene results in increased expression of GPNMB mRNA | CTD | PMID:20713471 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:733525 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of GPNMB mRNA | CTD | PMID:18648102 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736300 | 6480464 | Tretinoin results in increased expression of GPNMB mRNA | CTD | PMID:16249480 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GPNMB mRNA | CTD | PMID:16483693 |
| arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of GPNMB mRNA | CTD | PMID:18315880 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of GPNMB mRNA | CTD | PMID:18315880 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733525 | 6480464 | Benzo(a)pyrene results in decreased expression of GPNMB mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:733525 | 6480464 | Benzo(a)pyrene results in increased expression of GPNMB mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733525 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPNMB mRNA] | CTD | PMID:22228805 |
| bicalutamide | increases expression | ISO | RGD:736300 | 6480464 | bicalutamide results in increased expression of GPNMB mRNA | CTD | PMID:15638997 |
| cadmium dichloride | affects expression | ISO | RGD:733525 | 6480464 | Cadmium Chloride affects the expression of GPNMB mRNA | CTD | PMID:18974090 |
| cadmium sulfate | multiple interactions | ISO | RGD:736300 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPNMB mRNA | CTD | PMID:18654764 |
| carvedilol | decreases expression | EXP | | 6480464 | carvedilol results in decreased expression of GPNMB protein | CTD | PMID:20403466 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of GPNMB mRNA | CTD | PMID:18500788 |
| chloroquine | increases expression | EXP | | 6480464 | Chloroquine results in increased expression of GPNMB mRNA | CTD | PMID:19393257 |
| choline | multiple interactions | ISO | RGD:733525 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPNMB mRNA | CTD | PMID:20938992 |
| cobalt dichloride | multiple interactions | ISO | RGD:736300 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPNMB mRNA | CTD | PMID:18654764 |
| copper atom | multiple interactions | ISO | RGD:736300 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GPNMB mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:736300 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GPNMB mRNA | CTD | PMID:20971185 |
| cyclosporin A | decreases expression | ISO | RGD:736300 | 6480464 | Cyclosporine results in decreased expression of GPNMB mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GPNMB mRNA | CTD | PMID:21865292 |
| cyclosporin A | increases expression | ISO | RGD:733525 | 6480464 | Cyclosporine results in increased expression of GPNMB mRNA | CTD | PMID:19770486 |
| dasatinib (anhydrous) | increases expression | ISO | RGD:736300 | 6480464 | dasatinib results in increased expression of GPNMB mRNA | CTD | PMID:20579391 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of GPNMB mRNA | CTD | PMID:15763343 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of GPNMB mRNA] | CTD | PMID:20032058 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of GPNMB mRNA | CTD | PMID:20032058 |
| diazoxide | increases expression | ISO | RGD:733525 | 6480464 | Isoproterenol results in increased expression of GPNMB mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of GPNMB mRNA | CTD | PMID:21266533 |
| folic acid | multiple interactions | ISO | RGD:733525 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPNMB mRNA | CTD | PMID:20938992 |
| isoprenaline | increases expression | ISO | RGD:733525 | 6480464 | Isoproterenol results in increased expression of GPNMB mRNA | CTD | PMID:20003209 |
| L-methionine | multiple interactions | ISO | RGD:733525 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPNMB mRNA | CTD | PMID:20938992 |
| lucanthone | increases expression | ISO | RGD:736300 | 6480464 | Lucanthone results in increased expression of GPNMB mRNA | CTD | PMID:21148553 |
| melamine | increases expression | EXP | | 6480464 | melamine results in increased expression of GPNMB | CTD | PMID:23052191 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of GPNMB mRNA | CTD | PMID:19638242 |
| nickel sulfate | increases expression | ISO | RGD:736300 | 6480464 | nickel sulfate results in increased expression of GPNMB mRNA | CTD | PMID:16314067 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of GPNMB mRNA | CTD | PMID:18754875 |
| phenacetin | increases expression | EXP | | 6480464 | Phenacetin results in increased expression of GPNMB mRNA | CTD | PMID:17082564 PMID:17698508 |
| phenacetin | increases expression | EXP | | 6480464 | Phenacetin results in increased expression of GPNMB mRNA | CTD | PMID:17698508 PMID:17082564 |
| phenylhydrazine | increases expression | EXP | | 6480464 | phenylhydrazine results in increased expression of GPNMB mRNA | CTD | PMID:17698508 PMID:17082564 |
| phenylhydrazine | increases expression | EXP | | 6480464 | phenylhydrazine results in increased expression of GPNMB mRNA | CTD | PMID:17082564 PMID:17698508 |
| quercetin | decreases expression | ISO | RGD:736300 | 6480464 | Quercetin results in decreased expression of GPNMB mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:736300 | 6480464 | Raloxifene inhibits the reaction [Estradiol results in decreased expression of GPNMB mRNA] | CTD | PMID:21185374 |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of GPNMB mRNA | CTD | PMID:21865292 |
| tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of GPNMB mRNA | CTD | PMID:21865292 |
| tamoxifen | affects expression | ISO | RGD:733525 | 6480464 | Tamoxifen affects the expression of GPNMB mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:736300 | 6480464 | tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of GPNMB mRNA] | CTD | PMID:20032058 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GPNMB mRNA | CTD | PMID:15763343 |
| tetrachloromethane | affects expression | ISO | RGD:733525 | 6480464 | Carbon Tetrachloride affects the expression of GPNMB mRNA | CTD | PMID:17484886 |
| titanium dioxide | increases expression | ISO | RGD:733525 | 6480464 | titanium dioxide results in increased expression of GPNMB mRNA | CTD | PMID:19464567 |
| trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of GPNMB mRNA | CTD | PMID:17905399 |
| troglitazone | increases expression | ISO | RGD:736300 | 6480464 | troglitazone results in increased expression of GPNMB mRNA | CTD | PMID:19140230 |
| ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of GPNMB mRNA | CTD | PMID:15885361 |